FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2587185111> ?p ?o ?g. }

• W2587185111 abstract "Abstract Abstract 3425 Impaired anti-oxidant defenses and overproduction of reactive oxygen species (ROS) in individuals with Fanconi anemia (FA) are associated with a pro-oxidant state in this population. Cells derived from individuals with FA demonstrate increased sensitivity to DNA damage by ambient oxygen and increased frequency of chromosomal aberrations. Studies in animals and human subjects indicate that higher levels of and increased sensitivity to both ROS and tumor necrosis factor-alpha in individuals with FA play key roles in the pathogenesis of bone marrow failure (BMF) and neoplastic transformation. Accumulation of somatic DNA damage can be assessed using the Glycophorin A assay (GPA), which is designed to detect potentially inactivating mutations caused by chromosome loss, large deletions, or recombination events at the erythrocyte GPA locus. Previous cross-sectional studies in individuals with FA have shown a markedly increased frequency of GPA variant cells, demonstrating increased DNA damage. Knowledge regarding the timecourse of the accumulation of this somatic DNA damage is lacking. The goal of the current study is to evaluate serum ROS levels and accumulation of somatic DNA damage in individuals with FA to better understand the contribution of oxidative stress to disease phenotype and progression to marrow failure or malignant transformation. ROS levels were assessed ex vivo from peripheral blood and bone marrow of individuals with FA and healthy controls. We used a flow cytometric method to quantify ROS level by incubation of samples with CM-H2DCFDA, a cell-permeable fluorescence dye that reacts to a broad spectrum of ROS. Peripheral blood was also serologically typed on first submission using anti-M and anti-N sera. As only heterozygous (MN) individuals are informative, only these individuals were studied further. We used the GPA assay to quantify the accumulation of somatic cell damage in peripheral blood samples as measured by GPA variant cell frequencies. Peripheral blood and/or bone marrow samples from 19 individuals with FA and normal controls were evaluated for ROS on 23 occasions. ROS levels were variable, with 13 of the FA patients demonstrating high levels of ROS as measured by MFI signal strength. Overall ROS levels in individuals with FA were higher than those of normal control individuals (132% of control ROS levels, p<0.09, see Table). When stratified by age, older individuals with FA (age ≥10 years) had significantly higher ROS than normal controls (159% of control levels, p<0.05). Evaluation of 32 children at our center with FA by MN genotyping has identified 13 who are MN heterozygotes eligible for GPA testing. The frequency of NO and NN variant cell frequencies were markedly increased in children with FA (range of 1.2 to 187.5 fold and 0.46 to 201.8 fold over controls respectively). Additionally, longitudinal samples over a 5 year period revealed stable elevation of NO variant frequency with increasing NN variant cell frequency. NN variant frequency was closer to normal in younger individuals with FA and progressively increased with age and development of bone marrow failure.Mean age (years)ROS (% normal control)p-valueAll FA10.21320.09FA age ≥ 10 years12.81590.05FA age < 10 years7.7910.31 We demonstrate that individuals with FA have increased levels of ROS, and that ROS seems to increase with age. This correlates with accumulation of somatic DNA damage over time in this patient population. We hypothesize that ROS levels are low in younger FA individuals and progressively increase with age, resulting in accumulation of DNA damage. Additional longitudinal studies evaluating timecourse, intra-individual variability, and effects of complementation as well as environmental triggers are underway. We expect these studies to identify biomarkers that allow for earlier diagnosis leading to more timely therapy and to elucidate additional targets for novel therapeutic interventions to prevent BMF and myelodysplastic/leukemic transformation. Disclosures: No relevant conflicts of interest to declare." @default.
• W2587185111 created "2017-02-17" @default.
• W2587185111 creator A5006230191 @default.
• W2587185111 creator A5024968001 @default.
• W2587185111 creator A5028145044 @default.
• W2587185111 creator A5028850773 @default.
• W2587185111 creator A5034865327 @default.
• W2587185111 creator A5044873369 @default.
• W2587185111 creator A5062936778 @default.
• W2587185111 creator A5075213076 @default.
• W2587185111 creator A5079460556 @default.
• W2587185111 creator A5083989242 @default.
• W2587185111 creator A5085671725 @default.
• W2587185111 date "2011-11-18" @default.
• W2587185111 modified "2023-09-27" @default.
• W2587185111 title "Increased Oxidative Stress and Genomic Instability in Peripheral Blood and Bone Marrow of Individuals with Fanconi Anemia," @default.
• W2587185111 doi "https://doi.org/10.1182/blood.v118.21.3425.3425" @default.
• W2587185111 hasPublicationYear "2011" @default.
• W2587185111 type Work @default.
• W2587185111 sameAs 2587185111 @default.
• W2587185111 citedByCount "0" @default.
• W2587185111 crossrefType "journal-article" @default.
• W2587185111 hasAuthorship W2587185111A5006230191 @default.
• W2587185111 hasAuthorship W2587185111A5024968001 @default.
• W2587185111 hasAuthorship W2587185111A5028145044 @default.
• W2587185111 hasAuthorship W2587185111A5028850773 @default.
• W2587185111 hasAuthorship W2587185111A5034865327 @default.
• W2587185111 hasAuthorship W2587185111A5044873369 @default.
• W2587185111 hasAuthorship W2587185111A5062936778 @default.
• W2587185111 hasAuthorship W2587185111A5075213076 @default.
• W2587185111 hasAuthorship W2587185111A5079460556 @default.
• W2587185111 hasAuthorship W2587185111A5083989242 @default.
• W2587185111 hasAuthorship W2587185111A5085671725 @default.
• W2587185111 hasConcept C109159458 @default.
• W2587185111 hasConcept C134018914 @default.
• W2587185111 hasConcept C134935766 @default.
• W2587185111 hasConcept C143425029 @default.
• W2587185111 hasConcept C178169997 @default.
• W2587185111 hasConcept C203014093 @default.
• W2587185111 hasConcept C2776151105 @default.
• W2587185111 hasConcept C2778124228 @default.
• W2587185111 hasConcept C2780007613 @default.
• W2587185111 hasConcept C2780525284 @default.
• W2587185111 hasConcept C28328180 @default.
• W2587185111 hasConcept C2908647359 @default.
• W2587185111 hasConcept C48349386 @default.
• W2587185111 hasConcept C54355233 @default.
• W2587185111 hasConcept C552990157 @default.
• W2587185111 hasConcept C71924100 @default.
• W2587185111 hasConcept C86803240 @default.
• W2587185111 hasConcept C99454951 @default.
• W2587185111 hasConceptScore W2587185111C109159458 @default.
• W2587185111 hasConceptScore W2587185111C134018914 @default.
• W2587185111 hasConceptScore W2587185111C134935766 @default.
• W2587185111 hasConceptScore W2587185111C143425029 @default.
• W2587185111 hasConceptScore W2587185111C178169997 @default.
• W2587185111 hasConceptScore W2587185111C203014093 @default.
• W2587185111 hasConceptScore W2587185111C2776151105 @default.
• W2587185111 hasConceptScore W2587185111C2778124228 @default.
• W2587185111 hasConceptScore W2587185111C2780007613 @default.
• W2587185111 hasConceptScore W2587185111C2780525284 @default.
• W2587185111 hasConceptScore W2587185111C28328180 @default.
• W2587185111 hasConceptScore W2587185111C2908647359 @default.
• W2587185111 hasConceptScore W2587185111C48349386 @default.
• W2587185111 hasConceptScore W2587185111C54355233 @default.
• W2587185111 hasConceptScore W2587185111C552990157 @default.
• W2587185111 hasConceptScore W2587185111C71924100 @default.
• W2587185111 hasConceptScore W2587185111C86803240 @default.
• W2587185111 hasConceptScore W2587185111C99454951 @default.
• W2587185111 hasLocation W25871851111 @default.
• W2587185111 hasOpenAccess W2587185111 @default.
• W2587185111 hasPrimaryLocation W25871851111 @default.
• W2587185111 hasRelatedWork W1515924291 @default.
• W2587185111 hasRelatedWork W1550294225 @default.
• W2587185111 hasRelatedWork W1571751991 @default.
• W2587185111 hasRelatedWork W1981383667 @default.
• W2587185111 hasRelatedWork W2003678453 @default.
• W2587185111 hasRelatedWork W2015230497 @default.
• W2587185111 hasRelatedWork W2041405406 @default.
• W2587185111 hasRelatedWork W2047210179 @default.
• W2587185111 hasRelatedWork W2079821919 @default.
• W2587185111 hasRelatedWork W2129502482 @default.
• W2587185111 hasRelatedWork W2144339916 @default.
• W2587185111 hasRelatedWork W2156737696 @default.
• W2587185111 hasRelatedWork W2185818849 @default.
• W2587185111 hasRelatedWork W2385036469 @default.
• W2587185111 hasRelatedWork W2560816869 @default.
• W2587185111 hasRelatedWork W2588333345 @default.
• W2587185111 hasRelatedWork W2600928146 @default.
• W2587185111 hasRelatedWork W2969985785 @default.
• W2587185111 hasRelatedWork W2184509626 @default.
• W2587185111 hasRelatedWork W2478129042 @default.
• W2587185111 isParatext "false" @default.
• W2587185111 isRetracted "false" @default.
• W2587185111 magId "2587185111" @default.
• W2587185111 workType "article" @default.